DARIUSZ DUDEK. Country : POLAND. Application for the following position in the EAPCI Board: PRESIDENT-ELECT. Current position

Transcription

1 DARIUSZ DUDEK Country : POLAND Application for the following position in the EAPCI Board: PRESIDENT-ELECT Current position Chair of the Education and Training Committee of EAPCI Valve for Life Project Leader Poland (jointly with A. Witkowski) Profession Interventionalist Healthcare Professional (Nurse, Radiographer, Technician) working in PCI Industry Professional Other Additional Information Fellow of the ESC EAPCI Member Member of another ESC Association (beyond EAPCI) If yes, specify: Active in an ESC Member Country

2 If yes, specify your country of work: Poland Member of a National Cardiac Society If yes, specify: Polish Cardiac Society Member of an Interventional Working Group If yes, specify: Association of Cardiovascular Interventions of the Polish Cardiac Society (AISN PTK) Honorary Member of the Hungarian Society of Cardiology, Interventional Cardiology Working Group Honorary Member of the Russian Society of Cardiology, Interventional Cardiology Working Group General CV (as it pertains to PCI) 300 words max Date of Birth: 26 th of June 1969 Place of birth: Krakow, Poland. Education: Degree and Year Awarded Name and Location of Institution (State or Province and Country) 1994 MD Jagiellonian University Medical College, Krakow, Poland 1997 PhD thesis Jagiellonian University Medical College, Krakow, Poland Area of study: experimental interventional cardiology

3 I grade specialist in internal medicine II grade specialist in internal medicine 2006 Associate Professor and complied with specialization in cardiology Jagiellonian University Medical College, Krakow, Poland. Area of study: Internal medicine Jagiellonian University Medical College, Krakow, Poland. Area of study: Internal medicine Jagiellonian University Medical College, Krakow, Poland. Area of study: clinical cardiology Professor of Medicine and Cardiology at the Jagiellonian University Jagiellonian University Medical College, Institute of Cardiology, Krakow, Poland Professor of Medicine and Cardiology Professional Experience: Assistant: Department of Experimental Cardiology at Jagiellonian University Medical College in Krakow Assistant: Department of Cardiology at Jagiellonian University Medical College and University Hospital in Krakow Physician/ Deputy Head: Unit of Haemodynamics and Angiocardiography University Hospital in Krakow Acting as Physician-in-Chief: Unit of Haemodynamics and Angiocardiography University Hospital in Krakow 2013 present Head of the 2nd Department of Clinical Cardiology and Cardiovascular Interventions at the University Hospital of the Jagiellonian University

4 Scientific activity: The existing scientific output includes >500 scientific papers in prestigious international journals: NEJM, JAMA, Lancet, Circulation, JACC, EHJ, IJC, EuroIntervention, as well as chapters in textbooks. Total impact factor (IF) >1900. The number of citations >14,000 with Hirsch index of 52. Reviewer for numerous international scientific journals. Training: Experienced operator in PCI, TAVI, MitraClip, LAAO, PFO, ASD and endovascular procedures. Previous experience in EAPCI, ESC or your National Bodies Specifically, please indicate if you hold an Executive position (President, Vice President, President Elect) in a National Cardiac Society or in the ESC. If so, please indicate which one as well as the term of this position. Polish Cardiac Society, AISN Board President Elect Polish Cardiac Society, AISN Board President Polish Cardiac Society, AISN Board Past President Polish Cardiac Society, Scientific Program Committee Chair If you have been involved in EAPCI in the past, please specify the position(s) as well as the relevant date(s) In particular, please indicate if you served in: EAPCI Board (under M. Haude s leadership)? Yes EAPCI Board (under S. Windecker s leadership)? Yes EAPCI Board (under J. Fajadet s leadership)? No EAPCI Board (under C. Di Mario s leadership)? Yes EAPCI Board (under W. Wijns leadership)? Yes

5 If you answered yes to at least one of these questions, please provide details. EAPCI Board Chair of the Education and Training Committee + Valve for Life Project Leader in Poland EAPCI Board Chair of the National Cardiac Societies & International Affairs Committee EAPCI Board Chair of the Scientific and Programme Committee EAPCI Board Secretary and member of the EAPCI Executive Board Member of the CPC (Congress Program Committee) of the European Society of Cardiology in and Publications in the field of PCI (most important 10 publications) 1. Dudek D, Siudak Z, Janzon M, Birkemeyer R, Aldama-Lopez G, Lettieri C, Janus B, Wisniewski A, Berti S, Olivari Z, Rakowski T, Partyka L, Goedicke J, Zmudka K; EUROTRANSFER Registry Investigators. European registry on patients with STelevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab -- EUROTRANSFER Registry. Am Heart J Dec;156(6): Dudek D, Mielecki W, Burzotta F, Gasior M, Witkowski A, Horvath IG, Legutko J, Ochala A, Rubartelli P, Wojdyla RM, Siudak Z, Buchta P, Pregowski J, Aradi D, Machnik A, Hawranek M, Rakowski T, Dziewierz A, Zmudka K. Thrombus aspiration followed by direct stenting: a novel strategy of primary percutaneous coronary intervention in STsegment elevation myocardial infarction. Results of the Polish-Italian-Hungarian RAndomized ThrombEctomy Trial (PIHRATE Trial). Am Heart J Nov;160(5): Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D; ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J Dec;32(23): Dudek D, Di Mario C, De Luca G, Dziewierz A, Rakowski T. Interventions for STsegment elevation acute myocardial infarction. [in:] Percutaneous interventional cardiovascular medicine, Eeckhout, Serruys, Wijns, Vahanian, Van Sambeek, De Palma, publisher PCR publishing, Toulouse, France, Dudek D, Rzeszutko Ł, Zasada W, Depukat R, Siudak Z, Ochała A, Wojakowski W, Przewłocki T, Żmudka K, Kochman J, Lekston A, Gąsior M. Bioresorbable vascular scaffolds in patients with acute coronary syndromes: the POLAR ACS study. Pol Arch Med Wewn. 2014;124(12):

6 6. Dudek D, Dziewierz A, Brener SJ, Abizaid A, Merkely B, Costa RA, Bar E, Rakowski T, Kornowski R, Dressler O, Abizaid A, Silber S, Stone GW. Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1- year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial. Circ Cardiovasc Interv Feb;8(2):e Dudek D, Dziewierz A, Widimsky P, Bolognese L, Goldstein P, Hamm C, Tanguay JF, LeNarz L, Miller DL, Brown E, Ten Berg J, Montalescot G; ACCOAST Investigators. Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-st-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myocardial Infarction (ACCOAST) study. Am Heart J Nov;170(5): e2. 8. Daniec M, Nawrotek B, Sorysz D, Rakowski T, Dziewierz A, Rzeszutko Ł, Kleczyński P, Trębacz J, Tomala M, Żmudka K, Dudek D. Acute and long-term outcomes of percutaneous balloon aortic valvuloplasty for the treatment of severe aortic stenosis. Catheter Cardiovasc Interv Aug 1;90(2): Kleczynski P, Dziewierz A, Bagienski M, Rzeszutko L, Sorysz D, Trebacz J, Sobczynski R, Tomala M, Stapor M, Dudek D. Impact of frailty on mortality after transcatheter aortic valve implantation. Am Heart J Mar;185: Dudek D, Rzeszutko Ł, Onuma Y, Sotomi Y, Depukat R, Veldhof S, Ediebah D, Staehr P, Zasada W, Malinowski KP, Kaluza GL, Serruys PW. Vasomotor Response to Nitroglycerine Over 5 Years Follow-Up After Everolimus-Eluting Bioresorbable Scaffold Implantation. JACC Cardiovasc Interv Apr 24;10(8): What would you like to achieve if you were elected? motto: EAPCI Where the future of cardiology begins! Supporting and developing EAPCI flagship programs: o Support for 'Stent - save a life' project for effective treatment of myocardial infarction o Decrease of heterogeneity in access to diagnostic & therapeutic procedures in EAPCI countries o Development of new programs dedicated to other procedures for aging population of Europe o Support for 'Valve for life' programs for countries with low numbers of procedures Imaging and functional assessment of heart and newest generation devices to improve outcome of stable angina - Perfect PCI in complex cases

7 Innovations for all in EAPCI o Decision-making process in interventional cardiology supported by cloud and open source data o Sharing experience and knowledge in real time world wide - extended reality & virtual rooms for Heart Teams and consultations in any field of cardiology o Digital transformation of interventional cardiology with extended reality Education, certification and accreditation EAPCI program for interventional cardiology fellows If you were elected, how do you envisage to organize yourself to accommodate this very demanding additional commitment? Good time management and organizational skills Ability to keep things in perspective Focus on most important tasks Experience in serving in Boards and Committees of EAPCI and ESC for more than 10 years